E72.04 Cystinosis

Name of the Condition

• Cystinosis (ICD-10 Code: E72.04)

Summary

Cystinosis is a rare genetic disorder characterized by the accumulation of cystine, an amino acid, within cells. This buildup primarily affects the kidneys and eyes but can also impact other organs over time. The condition disrupts cellular function, leading to progressive tissue damage, particularly in renal and ocular tissues.

Causes

Cystinosis is caused by mutations in the CTNS gene, which encodes cystinosin, a protein responsible for transporting cystine out of lysosomes. These mutations impair cystine clearance, resulting in its toxic accumulation. The disorder follows an autosomal recessive inheritance pattern, requiring two mutated gene copies to manifest.

Risk Factors

• Family history of cystinosis or related lysosomal storage disorders.
• Consanguinity (parents who are close relatives) increasing recessive inheritance risk.
• Ethnic or geographic prevalence of specific CTNS variants in certain populations.

Symptoms

• Renal symptoms such as polyuria, polydipsia, and Fanconi syndrome (impaired reabsorption of glucose, amino acids, and electrolytes).
• Ocular symptoms including photophobia and corneal cystine crystal deposits.
• Growth retardation and developmental delays in children.
• Hypothyroidism or muscle weakness in advanced cases.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, laboratory testing for elevated cystine levels in white blood cells, and genetic testing for CTNS mutations. Urine analysis may show aminoaciduria, and imaging can detect renal or ocular abnormalities. Early diagnosis is critical to initiate timely treatment.

Treatment Options

Treatment focuses on reducing cystine accumulation and managing complications. Cysteamine, a medication that lowers intracellular cystine, is the primary therapy. Supportive care includes electrolyte replacement, vitamin supplementation, and management of renal dysfunction. In severe cases, kidney transplantation may be necessary.

Prognosis and Follow-Up

With early and consistent treatment, prognosis has improved, though long-term complications like renal failure or endocrine disorders may still occur. Regular monitoring of renal function, growth, and ocular health is essential. Lifelong follow-up with a multidisciplinary team (nephrologists, ophthalmologists, endocrinologists) is recommended.

Complications

• Progressive renal failure requiring dialysis or transplantation.
• Corneal damage leading to vision impairment.
• Endocrine disorders such as hypothyroidism or diabetes.
• Muscle weakness or neurological issues in advanced stages.

Lifestyle & Prevention

While cystinosis is genetic and not preventable, early detection through newborn screening (where available) can improve outcomes. Maintaining a balanced diet, staying hydrated, and adhering to prescribed medications are important for managing symptoms. Genetic counseling is advised for families with a history of the condition.

When to Seek Professional Help

Seek medical attention if symptoms like excessive thirst, frequent urination, or unexplained growth delays appear, especially in children. Prompt evaluation is necessary if ocular symptoms (e.g., photophobia) or signs of renal dysfunction (e.g., fatigue, swelling) develop.

Tips for Medical Coders

Document the presence of cystinosis and any associated complications (e.g., renal failure, ocular issues) to support accurate coding. Ensure CTNS mutation testing or cystine level results are noted if available, as these may confirm the diagnosis. Code E72.04 is specific to cystinosis and should not be used for other amino acid transport disorders.